Essex Investment Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Essex Investment Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-138,080	Closed	-$707K	–	466
2020 Q1	$707K	Sell	138,080 -7,351	-5%	-$29.7K	0.14%	195
2019 Q4	$663K	Buy	145,431 +6,828	+5%	+$33.3K	0.08%	288
2019 Q3	$848K	Sell	138,603 -15,804	-10%	-$94.2K	0.12%	232
2019 Q2	$940K	Buy	+154,407	New	+$1.04M	0.13%	227
2015 Q4	–	Sell	-12,461	Closed	-$50K	–	359
2015 Q3	$50K	Hold	12,461	–	–	0.01%	306
2015 Q2	$61K	Hold	12,461	–	–	0.01%	301
2015 Q1	$50K	Sell	12,461 -1,927	-13%	-$7.58K	0.01%	306
2014 Q4	$56K	Sell	14,388 -1,745	-11%	-$7.22K	0.01%	320
2014 Q3	$60K	Buy	+16,133	New	+$56.4K	0.01%	344
2013 Q4	–	Sell	-11,387	Closed	-$41K	–	435
2013 Q3	$41K	Sell	11,387 -24,826	-69%	-$105K	0.01%	354
2013 Q2	$181K	Buy	+36,213	New	+$168K	0.03%	318

Other funds holding CEMI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's CEMI Position: Q2 2020 in Review

Essex Investment Management sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 138,080 shares — an estimated $707K sold.

Essex Investment Management first reported a position in CEMI in Q2 2013 and held it in 11 quarters. The position peaked at $940K in Q2 2019. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

Essex Investment Management reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
Essex Investment Management sold 138,080 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $707K.
Essex Investment Management first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 11 quarters.
Essex Investment Management's Chembio diagnostics, Inc. position peaked at $940K in Q2 2019.
76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on Essex Investment Management's 13F filing for Q2 2020, filed 4 Aug 2020.